Develops biosimulation software for drug development and regulatory approval.
Jun 2026Revenue $408M/yrExpenses $409M/yr
No trend
Figures by year
When will Certara be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $408M and expenses $409M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $419M | $398M | $21.0M |
| Dec 2024 | $385M | $387M | −$1.73M |
| Dec 2023 | $354M | $395M | −$40.8M |
| Dec 2022 | $336M | $303M | $32.5M |
| Dec 2021 | $286M | $273M | $13.6M |
| Dec 2020 | $244M | $268M | −$24.4M |
| Dec 2019 | $209M | $189M | $19.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.